ACR 2022 Tweet by Md Yuzaiful Md Yusof

Tweet
Md Yuzaiful Md Yusof @Yuz6Yusof Nov 12, 2022
View on
#ACR22 Abstr#0002 @Dr_Alex_Oldroyd presented eminence-based recommendation for patients with inflammatory myopathy. Enhanced screening for those high risk. Studies needed to assess feasibility i.e. cost, positive and negative predictive value of test etc. @RheumNow
Image from Md Yuzaiful Md Yusof’s tweet

Related Content

Article General Rheumatology

Exploring Idiopathic Myopathies

2026 EULAR Press Release Jun 5, 2026
Idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions with substantial morbidity. EULAR in collaboration with the American College of Rheumatology (ACR) introduced classification criteria for the major subgroups in 2017,1 but there is a need for contemporary real-world data to understand the burden – and well as new ways of assessing disease activity.
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×